Characterization of the DNA polymerases induced by a group of herpes simplex virus type I variants selected for growth in the presence of phosphonoformic acid
- PMID: 6286645
Characterization of the DNA polymerases induced by a group of herpes simplex virus type I variants selected for growth in the presence of phosphonoformic acid
Abstract
Five independently derived variants of a herpes simplex virus type I (HSV-1) strain were plaque purified from a virus population passaged in 1 mM phosphonoformic acid (PFA). The DNA polymerase induced by the parent and PFA-resistant viruses were purified and characterized. No differences were observed among the enzymes with respect to their chromatographic properties, specific activities, or polypeptides resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The variant enzymes exhibited levels of PFA resistance which ranged from 15- to 25-fold. Resistance to PFA was always associated with a similar degree of resistance to its congener phosphonoacetic acid, but cross-resistance to beta-phenylphosphonoacetic acid was only seen with two of the five variant enzymes. PFA and pyrophosphate were mutually competitive in PPi exchange reactions, but in DNA synthetic reactions the levels of resistance to PFA and PPi were not equal. The apparent affinities of the enzymes for Mg2+ did parallel their affinities for PFA. Km values of dNTPs were about 2-fold higher than the parent virus enzyme for all of the variant enzymes except one which was 4-fold higher. The processivity of polymerization was apparently unaffected by the enzyme changes related to PFA resistance although one variant enzyme had a lower value. Resistance among the variant enzymes to the triphosphates of 9-(2-hydroxyethoxymethyl)guanine and 2',3'-dideoxyguanosine was directly related to the level of resistance to PFA. The data presented here indicated that (i) PFA resistance may result from several types of active site alterations, since the PFA-resistant enzymes were of three kinetically distinct types. Also, additional enzyme alterations, probably unrelated to PFA resistance, were detected in one enzyme. (ii) PFA and PPi possess some different binding determinants within the active center of herpes simplex virus type I DNA polymerase. (iii) PFA and the triphosphates of 9-(2-hydroxyethoxymethyl)guanine and 2',3'-dideoxyguanosine may have a common ultimate inhibitory mechanism.
Similar articles
-
Physical mapping of drug resistance mutations defines an active center of the herpes simplex virus DNA polymerase enzyme.J Virol. 1981 Sep;39(3):746-57. doi: 10.1128/JVI.39.3.746-757.1981. J Virol. 1981. PMID: 6270349 Free PMC article.
-
A comparison of phosphonoacetic acid and phosphonoformic acid activity in genital herpes simplex virus type 1 and type 2 infections of mice.Antiviral Res. 1981 Nov;1(4):225-35. doi: 10.1016/0166-3542(81)90013-9. Antiviral Res. 1981. PMID: 6280607
-
Sensitivity of arabinosyladenine-resistant mutants of herpes simplex virus to other antiviral drugs and mapping of drug hypersensitivity mutations to the DNA polymerase locus.J Virol. 1985 Feb;53(2):477-88. doi: 10.1128/JVI.53.2.477-488.1985. J Virol. 1985. PMID: 2982032 Free PMC article.
-
Antiviral effects of phosphonoformate (PFA, foscarnet sodium).Pharmacol Ther. 1989;40(2):213-85. doi: 10.1016/0163-7258(89)90097-1. Pharmacol Ther. 1989. PMID: 2543994 Review.
-
Antiviral effects of phosphonoformate (PFA, foscarnet sodium).Pharmacol Ther. 1982;19(3):387-415. doi: 10.1016/0163-7258(82)90074-2. Pharmacol Ther. 1982. PMID: 6201932 Review. No abstract available.
Cited by
-
A single-base change within the DNA polymerase locus of herpes simplex virus type 2 can confer resistance to aphidicolin.J Virol. 1987 Feb;61(2):388-94. doi: 10.1128/JVI.61.2.388-394.1987. J Virol. 1987. PMID: 3027369 Free PMC article.
-
Antiviral therapy: current concepts and practices.Clin Microbiol Rev. 1992 Apr;5(2):146-82. doi: 10.1128/CMR.5.2.146. Clin Microbiol Rev. 1992. PMID: 1576586 Free PMC article. Review.
-
In vitro mutagenesis of the herpes simplex virus type 1 DNA polymerase gene results in altered drug sensitivity of the enzyme.J Virol. 1989 Nov;63(11):4913-8. doi: 10.1128/JVI.63.11.4913-4918.1989. J Virol. 1989. PMID: 2552170 Free PMC article.
-
Characterization of the DNA- and dNTP-binding activities of the human cytomegalovirus DNA polymerase catalytic subunit UL54.Biochem J. 2007 Nov 1;407(3):331-41. doi: 10.1042/BJ20070853. Biochem J. 2007. PMID: 17672827 Free PMC article.
-
Polymerization activity of an alpha-like DNA polymerase requires a conserved 3'-5' exonuclease active site.Mol Cell Biol. 1991 Sep;11(9):4786-95. doi: 10.1128/mcb.11.9.4786-4795.1991. Mol Cell Biol. 1991. PMID: 1652064 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources